Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-08-09
2011-08-09
Anderson, Rebecca (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S139000
Reexamination Certificate
active
07994164
ABSTRACT:
The present invention provides a compound of Formula (I):or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 4072756 (1978-02-01), Arlesheim et al.
patent: 4999363 (1991-03-01), Oshima et al.
patent: 5024912 (1991-06-01), Neishi et al.
patent: 5378701 (1995-01-01), Ohshima et al.
patent: 5395610 (1995-03-01), King
patent: 0 345 747 (1989-12-01), None
patent: WO 99/33786 (1999-07-01), None
patent: WO 00/59884 (2000-10-01), None
patent: 2004052847 (2004-06-01), None
patent: WO 2004/052847 (2004-06-01), None
patent: 2005066153 (2005-07-01), None
patent: WO 2005/066161 (2005-07-01), None
patent: 2005110992 (2005-11-01), None
patent: WO 2006/015259 (2006-02-01), None
patent: 2006053024 (2006-05-01), None
patent: 2008053300 (2008-05-01), None
patent: 2008119918 (2008-10-01), None
patent: 2009080725 (2009-07-01), None
patent: 2009080730 (2009-07-01), None
patent: 2009094157 (2009-07-01), None
patent: 2010104721 (2010-09-01), None
Byrn et al., Solid-Sate Chemistry of Drugs, Second Edition, 1999, pp. 233-247.
Cheng et al., “Synthesis and Structure-Activity Relationships of 9-Substituted Acridines as Endothelia-A Receptor Antagonists,”Bioorg. Med. Chem. Let., vol. 6, No. 24, pp. 2999-3002 (1996).
Jadhav, “Discovery of orally bioavailable, non-steroidal mineralocorticoid receptor antagonists: A tale of three platforms,” slides for MR Antagonist Atlants ACS Meeting, Mar. 27, 2006.
Jadhav, Discovery of First, Orally Bioavailable, Non-Steroidal Mineralcorticoid Receptor Antagonists, slides, Feb. 11, 2003.
International Search Report and Written Opinion/ISA of the International Searching Authority of International Application No. PCT/US2008/085997, Mailing Date Mar. 27, 2009.
Reply to Written Opinion for International Application No. PCT/US2008/085997, Oct. 2009.
Notification of Transmittal of the International Preliminary Report on Patentability for International Application No. PCT/US2008/085997, Mar. 2010.
Gavardinas Konstantinos
Jadhav Prabhakar Kondaji
Anderson Rebecca
Eli Lilly and Company
Ginah Francis O.
Wilson Alexander
LandOfFree
Mineralocorticoid receptor antagonists and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mineralocorticoid receptor antagonists and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mineralocorticoid receptor antagonists and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2773615